Dailypharm Live Search Close

LG Chemical completed Vimovo's domestic copyright

By Lee, Tak-Sun | translator Choi HeeYoung

22.10.31 16:08:37

가나다라 0



LG Chem has acquired the domestic copyright of the complex "Vimovo," which combines NSAIDs-based anti-inflammatory analgesics (Naproxen) and PPI-based gastroesophageal reflux disease treatment ingredient Esomeprazole.

Vimovo is a product released in Korea by AstraZeneca Korea in 2012 and has been jointly selling it with LG Chem. As Vimovo's global copyright was recently transferred to a German pharmaceutical company, LG Chem seems to have bought domestic copyrights. According to industries on the 31st, Vimovo 500/20mg, which has been transferred and transferred by LG Chem, will be registered from the 1st of this month. LG Chem acquired the product from AstraZeneca Korea.

Until now, Vimovo

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)